Table 1.
The demographic and baseline characteristics of the patients (n=30).
| Characteristics | Dose: 1 capsule | Dose: 3 capsules | Dose: 6 capsules | P-value | Total |
|---|---|---|---|---|---|
| Patients (n) | 10 | 10 | 10 | -- | 30 |
| Age, mean ± SD (years) | 67.80±12.44 | 69.67±8.31 | 57.60±14.13 | 0.052 | 64.86±12.77 |
| Gender | M: n=4 F: n=6 |
M: n=4 F: n=6 |
M: n=2 F: n=8 |
0.549 | M: n=10 F: n= 20 |
| ESR120 | 76.6±48.5 | 59.3±35.4 | 87.8±41.7 | 0.465 | 74.6±42.4 |
| CRP (mg/dl) | 2.7±5.2 | 0.2±0.1 | 1.3±2.5 | 0.463 | 1.5±3.4 31.1±20.1 |
| BFI-T | 35.6±17.2 | 34.5±22.4 | 23.2±20.0 | 0.152 | |
| CSSD70 | 14.2±6.5 | 16.3±3.8 | 15.7±4.4 | 0.562 | 15.4±4.9 |
*: p-value<0.05; One-way ANOVA test was employed to compare values of the three groups for Age, ESR120, CRP, BFI-T, and CSSD70, and Chi-square test was used to compare the distribution of patients in different groups for Gender.
Abbreviations: BFI-T, Brief Fatigue Inventory Taiwan; CRP, C-reactive protein; CSSD70, Control status scale for diabetes; ESR, Erythrocyte sedimentation rate; F, Female; M, Male.